| | Authors [reference number] | Published year | Age (y) | Gravida | Para | Chief complaint | Locations | Maximum diameter (cm) | Initial examinations | Initial diagnosis | Treatment | Mitotic figures/10 HPF | Follow-up period (years) | Characteristics |
| | Ober [1] | 1959 | NM | NM | NM | Abnormal vaginal bleeding | Endometrium | NM | NM | NM | TAH | NM | NM | |
| | Zaloudek and Norris [2] | 1981 | 46 | NM | NM | Abnormal vaginal bleeding | Endometrium | NM | NM | NM | TAH,
BSO | 2 | 10 | | | 79 | NM | NM | Abnormal vaginal bleeding | Endometrium | NM | NM | NM | TAH,
BSO | 2 | 9 | | | 71 | NM | NM | Abnormal vaginal bleeding | Endometrium | NM | NM | NM | TAH,
BSO | 1 | 8 | | | 60 | NM | NM | Abnormal vaginal bleeding | Endometrium | NM | NM | NM | TAH,
BSO | 3 | 5 | | | 62 | NM | NM | Abnormal vaginal bleeding | Endometrium | NM | NM | Carcinosarcoma | TAH,
BSO,
radiation | 2 | 4 | | | 73 | NM | NM | Abnormal vaginal bleeding | Endometrium | NM | NM | NM | TAH,
BSO | 2 | 4 | | | 84 | NM | NM | Abnormal vaginal bleeding | Endometrium | NM | NM | NM | TAH,
BSO | 1 | 1.5 | | | 48 | NM | NM | Abdominal pain | Endometrium | NM | NM | NM | TAH,
BSO | 3 | 1 | | | 70 | NM | NM | Abnormal vaginal bleeding | Endometrium | NM | NM | NM | TAH,
BSO | 1 | Died of other disease | | | 66 | NM | NM | Abnormal vaginal bleeding | Endometrium | NM | NM | NM | TAH,
BSO | 2 | Died of other disease | |
| | Altaras et al. [3] | 1984 | 78 | 1 | 1 | Abnormal vaginal bleeding | Endometrium | 8 | Biopsy | Adenofibroma | TAH,
BSO | 0 | NM | |
| | Clement and Scully [4] | 1990 | 70 | 2 | 2 | Abnormal vaginal bleeding | Endometrium | 4.5 | Ultrasonography | Endometrial adenocarcinoma | TAH,
BSO | <1 | 3.5 | Myometrial invasion | | 51 | 4 | 2 | Abdominal pain, vomiting | Endometrium | NM | NM | NM | TAH,
BSO | <1 | 3.25 | Myometrial invasion, intravenous invasion |
| | Seltzer et al. [5] | 1990 | 28 | 0 | 0 | Abnormal vaginal bleeding, abdominal pain | Endometrium | NM | Laparoscope,
hysteroscope,
biopsy | Endometrial polyp | TAH,
LSO
(after recurrence) | <1 | 3 | Recurrence 2 years after excision |
| | Agarwal et al. [6] | 1991 | 38 | NM | multi | Hypermenorrhea, low back pain | Endometrium, endocervix | 12 | NM | Uterine myoma | TAH | <1 | 2 | Arising from the uterine body and the endocervix |
| | Miller and McClure [7] | 1992 | 68 | 2 | 2 | Abnormal vaginal bleeding, abdominal pain | Endometrium | 12 | Ultrasonography,
CT | Uterine myoma | TAH,
BSO,
radiation | 0 | 0.75 | Involvement of adenocarcinoma |
| | Gemer et al. [8] | 1995 | 48 | NM | NM | None | Uterine serosa | 6 | Ultrasonography | NM | TAH,
RSO | 0 | NM | Invasion through the uterine serosa to the right adnexa |
| | Horie et al. [9] | 1995 | 67 | NM | 0 | Abdominal pain | Endometrium | 6 | Ultrasonography,
CT | NM | TAH,
BSO | NM | 2 | |
| | Huang et al. [10] | 1996 | 70 | 4 | 4 | Abnormal vaginal bleeding | Endometrium | 7 | Ultrasonography,
biopsy | Myomatous polyp | TAH,
BSO | NM | NM | Treated with tamoxifen | | 56 | 6 | 3 | Abnormal vaginal bleeding | Endometrium | 5.5 | Ultrasonography,
biopsy | NM | TAH | NM | NM | Treated with tamoxifen |
| | Lee et al. [11] | 1998 | 31 | NM | 0 | Abdominal vaginal bleeding, hypermenorrhea | Endometrium | NM | CT, MRI, biopsy | Adenofibroma or adenosarcoma | TAH | NM | NM | |
| | Oshima et al. [12] | 2002 | 69 | 1 | 1 | Abnormal vaginal bleeding | Endometrium | 5 | Ultrasonography, CT,
MRI, biopsy | Endometrial polyp | TAH | NM | NM | Treated with tamoxifen |
| | Haberal et al. [13] | 2005 | 55 | NM | NM | Abnormal vaginal bleeding, anemia | Endocervix | 7 | Ultrasonography, biopsy | NM | TAH,
BSO | NM | NM | |
| | Konishi et al. [14] | 2006 | 42 | NM | 0 | Abnormal vaginal bleeding, anemia | Endometrium | 8 | Ultrasonography, CT,
MRI, biopsy | Mullerian mixed tumor | TAH,
BSO | 0 | NM | |
| | Bettaieb et al. [15] | 2007 | 31 | 0 | 0 | Abnormal vaginal bleeding | Endometrium | 13 | Ultrasonography | NM | Excision | <1 | 4 | | | 55 | 8 | 6 | Abnormal vaginal bleeding | Endometrium | 2 | Ultrasonography,
hysteroscope | NM | Excision with hysteroscope | <1 | 2 | | | 63 | 4 | 4 | Uterine prolapse | Endometrium | 5 | NM | Uterine prolapse | TAH | <1 | Not available | |
| | Skorupskaite et al. [16] | 2011 | 60 | 1 | 1 | Abnormal vaginal bleeding, abdominal pain | Endometrium | 4 | Ultrasonography,
hysteroscope, biopsy | Adenofibroma | TLH,
RSO | <1 | 5 | |
| | Navada et al. [17] | 2012 | 21 | NM | NM | Abnormal vaginal bleeding, abdominal pain | Endocervix | 14 | Ultrasonography,
CT, biopsy | Adenofibroma | TAH,
BSO | 0 | NM | |
| | Shi et al. [18] | 2015 | 45 | NM | NM | None | Endometrium, right ovary | 6.5 & 6.5 | Ultrasonography,
biopsy | Endometrial hyperplasia | TAH,
BSO | <1 | 1 | Treated with tamoxifen |
| | Present case | | 75 | 0 | 0 | None | Endometrium | 3 | Ultrasonography,
MRI, hysterofiberscopy, biopsy | Adenofibroma | TAH,
BSO | <1 | 1 | Coexisting endometrial polyp |
|
|
NM, not mentioned; TAH, total abdominal hysterectomy; BSO, bilateral salpingo-oophorectomy; LSO, left salpingo-oophorectomy; RSO, right salpingo-oophorectomy; TLH, total laparoscopic hysterectomy; CT, computed tomography; MRI, magnetic resonance imaging; and HPF, high power field.
|
